Plasmodium vivax:: Transmission-blocking immunity in a malaria-endemic area of Colombia

被引:0
|
作者
Arévalo-Herrera, M
Solarte, Y
Zamora, F
Mendez, F
Yasnot, MF
Rocha, L
Long, C
Miller, LH
Herrera, S
机构
[1] Inst Inmunol Valle, Cali, Colombia
[2] Malaria Vaccine & Drug Dev Ctr, Cali, Colombia
[3] Univ Valle, Sch Publ Hlth, Cali, Colombia
[4] NIAID, Malaria Vaccine Dev Branch, NIH, Bethesda, MD 20892 USA
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Plasmodium vivax transmission-block in g activity was assessed in sera from acutely infected patients from a malaria-endemic area in Colombia. We measured reduction in the number of oocysts that developed in the midguts of Anopheles albimanus mosquitoes artificially fed with blood from these patients. Of 88 mosquito batches that developed infections when parasites were mixed with normal AB human serum, one-third (36.4%) showed full transmission-blocking activity (>= 90% inhibition) when mixed with autologous sera, 29.6% showed partial activity (50-89%), 17.0% did not block transmission (0-50%), and 17% did not enhance transmission. Transmission-blocking activity correlated with antibody titer by an immunofluorescent antibody test and decreased with the serial dilution of the sera. This activity disappeared at a 1:4 dilution in most sera tested. Afro-Colombian individuals showed lower activity than other ethnic groups and febrile patients produced stronger inhibition than those without fever.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 50 条
  • [31] A metapopulation model for malaria with transmission-blocking partial immunity in hosts
    Julien Arino
    Arnaud Ducrot
    Pascal Zongo
    Journal of Mathematical Biology, 2012, 64 : 423 - 448
  • [32] Phagocytosis does not play a major role in naturally acquired transmission-blocking immunity to Plasmodium falciparum malaria
    Healer, J
    Graszynski, A
    Riley, E
    INFECTION AND IMMUNITY, 1999, 67 (05) : 2334 - 2339
  • [33] Transmission-blocking activities of artesunate, chloroquine, and methylene blue on Plasmodium vivax gametocytes
    Chaumeau, Victor
    Wasisakun, Praphan
    Watson, James A.
    Oo, Thidar
    Aryalamloed, Sarang
    Sue, Mu Phang
    Htoo, Gay Nay
    Tha, Naw Moo
    Archusuksan, Laypaw
    Sawasdichai, Sunisa
    Gornsawun, Gornpan
    Mehra, Somya
    White, Nicholas J.
    Nosten, Francois H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (09)
  • [34] Prevention of sporogony of Plasmodium vivax in Anopheles dirus mosquitoes by transmission-blocking antimalarials
    Coleman, RE
    Polsa, N
    Eikarat, N
    Kollars, TM
    Sattabongkot, J
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2001, 65 (03): : 214 - 218
  • [35] Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate
    Qiu, Yue
    Zhao, Yan
    Liu, Fei
    Ye, Bo
    Zhao, Zhenjun
    Thongpoon, Sataporn
    Roobsoong, Wanlapa
    Sattabongkot, Jetsumon
    Cui, Liwang
    Fan, Qi
    Cao, Yaming
    VACCINE, 2020, 38 (13) : 2841 - 2848
  • [36] Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro
    Blagborough, Andrew M.
    Sinden, Robert E.
    VACCINE, 2009, 27 (38) : 5187 - 5194
  • [37] MALARIA TRANSMISSION-BLOCKING VACCINES
    KASLOW, DC
    BATHURST, IC
    BARR, PJ
    TRENDS IN BIOTECHNOLOGY, 1992, 10 (11) : 388 - 391
  • [38] Restricted genetic heterogeneity of the Plasmodium vivax transmission-blocking vaccine (TBV) candidate Pvs48/45 in a low transmission setting: Implications for the Plasmodium vivax malaria vaccine development
    Asali, Soheila
    Raz, Abbasali
    Turki, Habibollah
    Mafakher, Ladan
    Razmjou, Elham
    Solaymani-Mohammadi, Shahram
    INFECTION GENETICS AND EVOLUTION, 2021, 89
  • [39] TARGET ANTIGENS OF TRANSMISSION-BLOCKING IMMUNITY ON GAMETES OF PLASMODIUM-FALCIPARUM
    RENER, J
    GRAVES, PM
    CARTER, R
    WILLIAMS, JL
    BURKOT, TR
    JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (03): : 976 - 981
  • [40] Asymptomatic Plasmodium vivax parasitaemia in the low-transmission setting: the role for a population-based transmission-blocking vaccine for malaria elimination
    Martin, Thomas C. S.
    Vinetz, Joseph M.
    MALARIA JOURNAL, 2018, 17